CD274 and neoplasm: In the present study, we identified PD-L1 positivity (≥1% tumor cells, SP142 Ab clone) in 16.5% of samples from a large cohort of 430 clinically annotated solid tumor patients, and noted significant relationship with MMR status across anatomic tumor types (P = 0.01).